RE: Trading6 May 2020 12:01
Is this not pretty much sure as dammit previous RNS about at home trials? Or Do you mean results?
"Southampton, UK - 30 April 2020: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it has received approvals to extend the SG016 trial to patients with SARS-CoV-2 in the home environment"